Fig. 3

Progression-free (top) and overall (bottom) survival among patients in the setting of ixabepilone dose reductions (left, none; middle, one dose reduction, right, two dose reductions).
Progression-free (top) and overall (bottom) survival among patients in the setting of ixabepilone dose reductions (left, none; middle, one dose reduction, right, two dose reductions).